Fresenius Medical Care (FME) Stock Price, Fundamentals & Analysis

What FME does

Fresenius Medical Care (FME) is a healthcare company that provides dialysis and related services for individuals with renal diseases. It operates outpatient dialysis clinics, supplies materials and training for patients, and delivers dialysis services under contract to hospitals in the United States for hospitalized patients with end-stage renal disease or acute kidney failure. The company also develops, manufactures, and distributes health care products such as hemodialysis machines, peritoneal dialysis cyclers, solutions, concentrates, bloodlines, and renal pharmaceuticals. Fresenius Medical Care is listed on the Xetra market and is part of the broader DAX universe, alongside peers like Bayer (BAYN) and Siemens Healthineers (SHL).

Key numbers explained

• The current price of 39,8 EUR reflects the latest trading value of one share on Xetra.
• The trailing P/E ratio of 12 shows how much investors pay per euro of the company's last twelve months of earnings.
• The forward P/E ratio of 9,2 uses expected future earnings and is often read as a more optimistic valuation gauge.
• The dividend yield of 3,74% indicates the annual dividend payment as a percentage of the current share price.
• The ex-dividend date of May 22, 2026 is the cutoff: buyers on or after this date do not receive the next dividend.
• The beta of 0,83 suggests the stock has historically moved less than the overall market.
• The price-to-book ratio of 0,84 means the market price is below the company's book value per share.
• The debt-to-equity ratio of 81,1% shows the company's leverage, comparing total debt to shareholders' equity.

What to watch

Investors tracking Fresenius Medical Care often monitor changes in the dividend yield and the ex-dividend date when planning income-oriented strategies. The trailing P/E ratio and forward P/E ratio are commonly compared with peers such as Ramsay Health Care (RHC) to gauge relative valuation. For broader context, the stock's position among Xetra stocks and its relationship with other healthcare names like Merck (MRK) can help frame sector trends. General factors that typically affect this kind of stock include regulatory changes in healthcare, reimbursement rates for dialysis services, product innovation in medical devices, and macroeconomic conditions that influence patient volumes and capital costs.